ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

U2 rock star Bono has been a prominent activist in the global fight against HIV/AIDS, including working with the George W.

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The Ghana HIV and AIDS Network (GHANET) is taking a proactive and strategic approach to combat the nation's HIV epidemic, focusing on a demographic often overlooked in health-seeking behaviours.

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...

This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept.

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in ...